Time line | Lineage | Basal media* | Growth factors | Small molecules | |
---|---|---|---|---|---|
Base | Supplement | ||||
S0D0 | Pluripotent stem cell | mTeSRTM1 |  |  | 10 µM Y27632 |
S0D1 | Â | mTeSRTM1 | Â | Â | Â |
S1D1–D3 | Definitive endoderm | MCDB131 | 2 mM GlutaMAX | 100 ng/ml GDF8 | 1 µM MCX (S1D1 only) |
0.5% FAF-BSA | 0.1 µM MCX (S1D2 only) | ||||
10 mM Glucose (Final concentration) |  | ||||
2.7Â g/L bicarbonate (Final concentration) | Â | ||||
1:5000 ITS-X (3D differentiation only) | Â | ||||
S2D1–D3 | Primitive gut tube | MCDB131 | 2 mM GlutaMAX | 50 ng/ml FGF7 |  |
1% FAF-BSA | |||||
10 mM Glucose (Final concentration) | |||||
2.7Â g/L bicarbonate (Final concentration) | |||||
0.25Â mM Vitamin C | |||||
S3D1–D2 | Posterior foregut | BLAR | 2 mM GlutaMAX | 25 ng/ml FGF7 | 1 µM Retinoic Acid |
2% FAF-BSA | 0.25 µM SANT-1 | ||||
10 mM Glucose (Final concentration) | 300 nM TPPB | ||||
3.6Â g/L bicarbonate (Final concentration) | 250Â nM LDN | ||||
1:200 ITS-X | Â | ||||
0.25Â mM Vitamin C | Â | ||||
S4D1–D3 | Pancreatic progenitor | BLAR | 2 mM GlutaMAX | 2 ng/ml FGF7 | 0.05 µM Retinoic Acid |
2% FAF-BSA | 0.25 µM SANT-1 | ||||
10 mM Glucose (Final concentration) | 200 nM TPPB | ||||
3.6Â g/L bicarbonate (Final concentration) | 250Â nM LDN | ||||
1:200 ITS-X | Â | ||||
0.25Â mM Vitamin C | Â | ||||
S4D4 Aggrewell aggregation | Pancreatic progenitor | BLAR | 2 mM GlutaMAX | 2 ng/ml FGF7 | 0.05 µM Retinoic Acid |
2% FAF-BSA | 0.25 µM SANT-1 | ||||
10 mM Glucose (Final concentration) | 200 nM TPPB | ||||
3.6Â g/L bicarbonate (Final concentration) | 250Â nM LDN | ||||
1:200 ITS-X | 1:50 Laminin 521 (100 µg/mL stock) | ||||
0.25 mM Vitamin C | 10 µM Y27632 | ||||
S5D1–D3 PBS-Mini: 60 rpm | Endocrine progenitor | BLAR | 2 mM GlutaMAX |  | 50 nM Retinoic Acid |
2% FAF-BSA | 0.25 µM SANT-1 | ||||
20 mM Glucose (Final concentration) | 10 µM ALK5i | ||||
2.7Â g/L bicarbonate (Final concentration) | 100Â nM LDN | ||||
1:200 ITS-X | 1 µM T3 | ||||
10 µM ZnSO4 | 10 µg/ml heparin | ||||
 | 10 µM Y27632 (S5D1 only) | ||||
 | 8 U/mL DNAse (S5D1 only) | ||||
S6D1-D7 PBS-Mini: 60 rpm | Immature endocrine cells | BLAR | 2 mM GlutaMAX |  | 10 µM ALK5i |
2% FAF-BSA | 100Â nM LDN | ||||
20 mM Glucose (Final concentration) | 1 µM T3 | ||||
2.7Â g/L bicarbonate (Final concentration) | 100Â nM Gamma secretase inhibitor | ||||
1:200 ITS-X | 10 µg/mL heparin | ||||
10 µM ZnSO4 |  | ||||
S7 D1–D8+  PBS-Mini: 60 rpm | Maturing endocrine islet-like cells | BLAR | 2 mM GlutaMAX |  | 10 nM T3 |
2% FAF-BSA | 1Â mM N-Acetyl cysteine | ||||
20 mM Glucose (Final concentration) | 0.5 µM ZM 447 | ||||
1:200 ITS-X | 10 µg/mL heparin | ||||
1:200 RPMI Vitamin supplement | 5 µM AZT (S7D1-D4 only) | ||||
1:200 MEM Non-essential amino acid | 1 µM DEZA (S7D1-D4 only) | ||||
1:2000 Lipid concentrate | Â | ||||
1:200 Sodium pyruvate | Â | ||||
1:2000 Trace elements A | Â | ||||
1:2000 Trace elements B | Â | ||||
2.7Â g/L bicarbonate (Final concentration) | Â |